Back to Results
First PageMeta Content
Pharmaceutical sciences / Research / Pharmacology / Drug safety / Pharmaceutical industry / EudraVigilance / European Medicines Agency / Pharmacovigilance / Uppsala Monitoring Centre / Clinical research / Pharmaceuticals policy / Health


EV access policy July 2014 fixed
Add to Reading List

Document Date: 2014-08-05 10:34:01


Open Document

File Size: 643,77 KB

Share Result on Facebook

Company

EudraVigilance Expert Working Group / ICH E2B Expert Working Group / European Risk Management Facilitation Group / Stakeholder Group / Medicines Regulatory Authorities / Health Care Professional Working Group / /

/

Event

Product Release / /

Facility

EudraVigilance Data Warehouse / Canary Wharf / /

IndustryTerm

spontaneous reporting systems / quality management / healthcare professionals / signal management / data-processing network / regulatory network / data protection law / medicinal product / data processing operations / medicinal products / /

MusicGroup

the World / the Union / the WHO / occurring in the Union / /

Organization

World Health Organisation / Uppsala Monitoring Centre / European Medicines Agency / Medicines Agency / European Commission / Consumers’ Working Party / EEA / European Union / European Parliament / WHO Uppsala Monitoring Centre / contact An / EMA Management Board / Agency’s Management Board / Committee for Human Medicinal Products / Pharmacovigilance Risk Assessment Committee / /

/

Position

EXECUTIVE / Data Protection Officer / General / Data Protection Supervisor / Contents EXECUTIVE / /

Product

EudraVigilance Access Policy / Access Policy / /

ProgrammingLanguage

EC / /

PublishedMedium

the European / /

Technology

Data Warehouse / /

URL

www.ema.europa.eu/contact / http /

SocialTag